Scheduling, administration, biomarkers, and practical guidance.
GI tolerance adaptation period. Do not skip.
Assess GI tolerability before proceeding.
Maintenance dose for type 2 diabetes. Weight management continues titrating.
Intermediate step. Monitor for dose-limiting GI effects.
Target maintenance dose for weight management (Wegovy). Slow titration reduces GI discontinuation from 5-10% to 2-3%.
Rybelsus. 14 mg oral daily is roughly equivalent to 1 mg SC weekly in systemic exposure.